Abstract
In 1987, Professor Roy Pounder launched Alimentary Pharmacology and Therapeutics and in that very issue, he was the senior author on a retrospective study of cyclosporin for the management of Crohn's disease.1 Since that time, the incidence and prevalence of inflammatory bowel disease (IBD) has risen exponentially, reaching all corners of the globe and all ethnicities. Alimentary Pharmacology and Therapeutics has provided gastroenterologists with a broad spectrum of clinically relevant journal articles for 37 years through 60 volumes of high-quality publications. The breadth of these is reflected in the range of journal articles that we have assembled for this special IBD edition of Alimentary Pharmacology and Therapeutics. Looking back through the journal listings, this is the ninth special edition focused on IBD, but the first for 16 years. As associate editors, we are proud of this collection of cutting-edge reviews written by an exceptional group of IBD experts, all with strong connections to the journal.